Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

By R. Gray, J. Barnwell, C. McConkey, R. Hills, N. Williams, David J. Kerr. The Lancet, 2007

1,380 citations recorded by the source corpus.

Subfields: Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/f663d0a70c33a2b1273e7839a7352574675b3016

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. C. Rödel
2. R. Glynne-Jones
3. E. Tiret
4. A. Cervantes
5. G. Brown
6. L. Wyrwicz
7. D. Arnold

Citations in the corpus

• Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2017, positive): “After surgery alone for rectal cancer, individual trials and meta-analyses indicate that there is a benefit for adjuvant 5-FUbased ChT in terms of DFS and OS [89, 90], but the magnitude of benefit is smaller than for colon cancer.”